Next Article in Journal
Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment
Next Article in Special Issue
Perylenequione Derivatives with Anticancer Activities Isolated from the Marine Sponge-Derived Fungus, Alternaria sp. SCSIO41014
Previous Article in Journal
Extending the “One Strain Many Compounds” (OSMAC) Principle to Marine Microorganisms
Previous Article in Special Issue
Novel Natural Products from Extremophilic Fungi
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sorbicillasins A–B and Scirpyrone K from a Deep-Sea-Derived Fungus, Phialocephala sp. FL30r

1
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
2
Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2018, 16(7), 245; https://doi.org/10.3390/md16070245
Submission received: 6 June 2018 / Revised: 18 July 2018 / Accepted: 18 July 2018 / Published: 23 July 2018
(This article belongs to the Special Issue Natural Products from Marine Fungi)

Abstract

:
Two new nitrogen-containing sorbicillinoids named sorbicillasins A and B (1 and 2) and a new 3,4,6-trisubstituted α-pyrone derivative, scirpyrone K (3), together with two known biosynthetically related polyketides (45), were isolated from the deep-sea-derived fungus Phialocephala sp. FL30r by using the OSMAC (one strain-many compounds) method. The structures of 13, including absolute configurations, were deduced based on MS, NMR, and time-dependent density functional theory (TD-DFT) calculations of specific ECD (electronic circular dichroism) spectra. Compounds 1 and 2 possessed a novel hexahydropyrimido[2,1-a] isoindole moiety, and compound 3 exhibited weak radical scavenging activity against DPPH (2,2-diphenyl-1-picrylhydrazyl) with an IC50 value of 27.9 μM.

Graphical Abstract

1. Introduction

Filamentous fungi are known as prolific microbial factories for the production of a wide range of metabolites having extensive biological activity [1]. However, previous genomic analysis of fungi revealed a large number of biosynthetic genes that were unexpressed under common laboratory culture conditions, which offers a great opportunity for natural product discovery research [2]. To induce the expression of silent biogenetic clusters and increase the chemical diversity of the secondary metabolome, the approach “one strain-many compounds (OSMAC)” has been widely and successfully practiced by altering media constituents and manipulating culture conditions [3,4,5].
During our ongoing search for bioactive secondary metabolites from deep-sea-derived fungi [6], the fungal strain Phialocephala sp. FL30r was found to be an extensive producer of diverse polyketides, including monomeric sorbicillinol derivatives, bisorbicillinoids, and trisorbicillinoids [7,8,9,10]. Based upon the biosynthetic capability of this strain, the OSMAC approach was employed to further enhance the structural diversity of secondary metabolites. When the fungal strain was cultured on a mannitol-based medium, the HPLC-UV profile (Figure S1) of the fungal extract differed from those generated previously from culture in a potato-based medium [7,8,9,10]. Further chemical assessment of the organic extract led to the isolation of two new nitrogen-containing sorbicillinoids named sorbicillasins A and B (1 and 2) and a new 3,4,6-trisubstituted α-pyrone derivative, scirpyrone K (3), together with two known biosynthetically related polyketides (45) [11,12]. Among them, compounds 1 and 2 are sorbicillin-asparagine hybrids possessing a unique hexahydropyrimido[2,1-a] isoindole tricyclic skeleton. The radical scavenging activities of the new compounds against DPPH (2,2-diphenyl-1-picrylhydrazyl) were tested, and 3 showed weak activity with an IC50 value of 27.9 µM. Herein, we report the details of the isolation, structure elucidation, and biological activities of compounds 15.

2. Results and Discussion

The fungus Phialocephala sp. FL30r was cultured in mannitol-based medium (45.0 L) with agitation. The EtOAc extract (15.0 g) of fermentation was fractionated by silica gel column chromatography, Sephadex LH-20 column chromatography, medium-pressure preparation liquid chromatography (MPLC; ODS), and semi-preparative HPLC to afford compounds 1 (4.5 mg), 2 (2.7 mg), 3 (7.0 mg), 4 (4.4 mg), and 5 (2.0 mg) (Figure 1).
Sorbicillasins A and B (1 and 2) were both obtained as yellow oils with the molecular formula C19H22N2O6 according to the protonated peak at m/z 375.1550 (Figure S9, calcd. for C19H23N2O6, 375.1151) and the sodinated peak at m/z 397.1376 (Figure S17, calcd. for C19H22N2O6Na, 397.1370) as analyzed by HRESIMS, respectively. The 1D NMR data (Table 1) of 1 and 2 were highly similar. Each set of data suggested the presence of 19 carbons, assigned as 3 methyls, 3 methylenes, 3 methines with 2 vinyl moieties, and 10 non-protonated carbons, including 3 carbonyls. Among the three carbonyls, one was proven to be a carboxylic group based on the exchangeable proton signal at δH 13.12, together with the IR absorptions at 3524 and 1670 cm−1. The planar structures of 1 and 2 were determined to be the same by interpretation of 1D and 2D NMR spectroscopic data (Figure 2, Table 1, Figures S2–S7, and Figures S11–S15). The methylated olefinic hydrocarbon chain (from C-16 to C-20) was established by the sequential COSY correlations of H2-16/H2-17/H-18/H-19/H3-20. The presence of a fully substituted benzene ring was indicated by the aromatic non-protonated carbon signals (C-1/C-6) in the 13C-NMR spectrum. Consistent with this analysis, diagnostic HMBC correlations were observed from H3-14 to C-1, C-2, and C-3; from H3-15 to C-3, C-4, and C-5; from 3-OH to C-2, C-3, and C-4; and from 5-OH to C-6. The presence of a tetrahydro-pyrimidinone ring was postulated based on the COSY correlation (H-10/H-11) and the HMBC correlations from 8-NH to C-7, C-9, and C-10; from H2-10 to C-9 and C-11; and from H-11 to C-7, C-9, and C-10. The HMBC correlations from 8-NH and H2-16 to C-6 confirmed the connection of the tetrahydro-pyrimidinone structure and the benzene ring. The HMBC correlation from H2-16 to C-7 positioned the olefinic chain at C-7. Based on the key HMBC correlations from H-11 to C-13 and C-21, together with the chemical shift of C-11 (δC 48.2) and C-13 (δC 169.0), two carbonyls (C-13 and C-21) were connected to N-12 and C-11, respectively. Finally, when accounting for the molecular formula and the degree of unsaturation, C-1 was linked to C-13, and one hydroxyl group was attached to C-21, thus completing the planar structure of 1.
The relative configuration of 1 was deduced based on the NOESY correlations (Figure 3 and Figure S8). The E geometries of double bonds in the olefinic chain were deduced by the correlations between H-17 and H-19 and between H-18 and H-20. The NOEs of H-10a/H-11 and H-10b/H-16 indicated that the carboxylic group and methylated olefinic hydrocarbon chain were to the same face of the pyrimidinone ring. Thus, the relative configuration of 1 was suggested to be 7R*, 11S*. The absolute configuration of 1 was determined by comparing the experimental ECD curve with the one calculated from the truncated model (7R,11S)-1a using time-dependent density functional theory (TD-DFT). The DFT re-optimization of the initial MMFF (Merck molecular force field) minima was performed at the B3LYP/6-31+g(d) level with a polarizable continuum model (PCM) solvent for MeOH. The strong agreement between the calculated ECD spectra of (7R,11S)-1a with experimental results suggested the absolute configuration of 1 as 7R, 11S (Figure 4 and Figure S27).
The slight discrepancies of 1 and 2 in the NMR data suggested they might be isomers. Further NOESY correlation (Figure 3 and Figure S16) of H-11/H2-16 indicated that the relative configuration of 2 was 7S*, 11S*. The absolute configuration of 2 was then further determined as 7S, 11S by the agreement between the calculated ECD spectra of 2 and the experimental results according to the truncated model (7S,11S)-1b (Figure 5 and Figure S28).
Compound 3 was obtained as a white amorphous powder, and the molecular formula was determined to be C10H12O5 by HRESIMS peaks at m/z 213.0764 (Figure S25, calcd. for C10H13O5, 213.0757). The 1D NMR data (Table 2) of 3 suggested the presence of two methyls, including one methoxy (δC 52.0 and δH 3.58), two methylenes, one methine, and five non-protonated carbons. Comparison of the 1H and 13C NMR spectra (Figures S19–S21) of 3 with those of scirpyrone H revealed the presence of an extra methyl group (δC 8.8 and δH 1.72) and the replacement of the 4-methoxyl group by a 4-hydroxyl group in 3 [13]. Further 2D NMR (Figures S22–S24) data and key HMBC correlations from H3-11 to C-2, C-3, and C-4, from H-5 to C-3, C-4, and C-6, and from 4-OH to C-3, C-4, and C-5 supported the locations of the 4-hydroxyl group and the 11-methyl group.
Compounds 4 and 5 were identified as trichopyrone [11] and peniginseng A [12] based on the comparison of their spectroscopic data (NMR and MS) with those reported in the literature.
The cytotoxicity against K562 and MGC-803 cell lines [14,15] and the radical scavenging activity [16] against DPPH of the new compounds 13 were evaluated. All of them were non-cytotoxic. Compound 3 exhibited weak activity against DPPH with an IC50 value of 27.9 μM (ascorbic acid was used as a positive control with an IC50 value of 14.2 μM), whereas compounds 1 and 2 were not active (IC50 > 500 μM). According to the literature [11,12], the known compound 4 showed weak radical scavenging activity, but the radical scavenging activity of 5 has not been reported.
Sorbicillinoids belong to a large family of polyketides with highly diverse carbon skeletons and bioactivities [17]. Since first reported in 1948, about 90 sorbicillinoids have been isolated from terrestrial- and marine-derived fungi [17]. Among them, the nitrogen-containing analogues are rare, with only eight related cases reported, including sorbicillactones A and B [18], sorbicillinoid urea [19], and sorbicillamines A–E [20]. The sources of nitrogen atoms in the reported nitrogenous sorbicillinoids were deduced to be l-alanine, urea, and an aminotransferase enzyme [18,19,20]. In this report, sorbicillasins A and B (1 and 2) were probably formed by adding a whole molecule of l-asparagine to 2′,3′-dihydrosorbicillin [21] (Figure 6) via sequential intermolecular/intramolecular nucleophilic reactions. The hexahydropyrimido[2,1-a] isoindole ring system in compounds 1 and 2, which compose a 6/5/6 tricyclic ring system, have not been found in nature, with only related synthetic structures reported [22,23,24]. The above result shows that the OSMAC approach is a useful method to discover structurally diversified metabolites from a deep-sea-derived fungal strain.

3. Materials and Methods

3.1. General Experimental Procedures

UV spectra were recorded on a Beckman DU 640 spectrophotometer (Beckman Coulter Inc., Brea, CA, USA). Specific rotations were measured with a JASCO P-1020 digital polarimeter (JASCO Corporation, Tokyo, Japan). ESIMS were obtained on a Thermo Scientific LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) or a Micromass Q-TOF ULTIMA GLOBAL GAA076 LC Mass spectrometer (Wasters Corporation, Milford, MA, USA). CD spectra were measured on a JASCO J-815 spectropolarimeter (JASCO Corporation, Tokyo, Japan). NMR spectra were recorded with an Agilent 500 MHz DD2 spectrometer (Agilent Technologies Inc., Santa Clara, CA, USA) using TMS as an internal standard, and chemical shifts were recorded as δ-values. Semi-preparative HPLC (Hitachi, Tokyo, Japan) was performed on an ODS column (YMC-Pack ODS-A, 10 mm × 250 mm, 5 μm, 3 mL/min, YMC. Co., Ltd., Tokyo, Japan). Medium-pressure preparation liquid chromatography (MPLC) was performed on a Bona-Agela CHEETAHTM HP100 (Beijing Agela Technologies Co., Ltd., Beijing, China). Column chromatography (CC) was performed with silica gel (200–300 mesh, Qingdao Marine Chemical Inc., Qingdao, China) and Sephadex LH-20 (Amersham Biosciences, San Francisco, CA, USA) [25].

3.2. Fungal Material

The fungal strain FL30r has been previously described [7,8,9,10]. The strain was deposited at the Key Laboratory of Marine Drugs, the Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.

3.3. Fermentation and Extraction

Erlenmeyer flasks (500 mL) containing 150 mL fermentation medium were directly inoculated with spores. The media contained mannitol (20.0 g), glucose (20.0 g), peptone (10.0 g), yeast extract (5.0 g), corn syrup (1.0 g), KH2PO4 (0.5 g), and MgSO4·7H2O (0.3 g) dissolved in 1 L of naturally collected seawater (Huiquan Bay, Yellow sea). The flasks were cultured at 28 °C on a rotary platform shaker at 180 rpm for 9 days. The fermentation broth (45.0 L) was filtered through cheese cloth to separate the supernatant from mycelia. The supernatant was extracted with EtOAc (3 × 45.0 L) and evaporated under reduced pressure to produce the crude gum (15.0 g) [26].

3.4. Isolation

The extract was subjected to VLC (vacuum liquid chromatography) and a stepped gradient elution with petroleum ether/EtOAc (10:0 to 0:10), and EtOAc/MeOH (10:0 to 0:10) was applied to give eight fractions (Fr.1 to Fr.8). Fr.5 was further separated on a Sephadex LH-20 column eluted with MeOH and provided four subfractions (Fr.5-1 to Fr.5-4). Fr.5-3 was then separated by semi-preparative HPLC with MeOH/H2O (40:60) as a mobile phase to give compound 1 (4.5 mg, tR 17 min). Fr.6 was further separated by MPLC (C-18 ODS) using a stepped gradient elution with MeOH/H2O (20:80 to 100:0) to yield five subfractions (Fr.6-1 to Fr.6-5). Fr.6-1 was separated on a Sephadex LH-20 column eluted with MeOH to provide four subfractions (Fr.6-1-1 to Fr.6-1-4). Fr.6-1-3 was further separated by MPLC (C-18 ODS) using a stepped gradient elution with MeOH/H2O (30:70 to 100:0) to furnish nine subfractions (Fr.6-1-3-1 to Fr.6-1-3-9). Fr.6-1-3-5 was further separated by semi-preparative HPLC eluted with MeOH/H2O (30:70) to provide compound 3 (7.0 mg tR 16 min). Fr.6-1-3-9 was further purified by semi-preparative HPLC eluted with MeCN/H2O (25:75) to give compound 2 (2.7 mg, tR 16 min). Fr.6-1-4 was further separated by semi-preparative HPLC eluted with MeOH/H2O (60:40), thus providing compounds 4 (4.4 mg, tR 13 min) and 5 (2.0 mg, tR 35 min).
Sorbicillasin A (1): pale yellow oil, [ α ] D 25 −15.5 (c 0.15, MeOH); UV (MeOH) λmax (log ε): 220 (2.65), 261 (2.01), 307 (1.80) nm; IR (KBr) νmax 3292, 2906, 1670, 1457, 1362, 1207, 1146, 899 cm−1, see Figure S10; ECD (1 mM MeOH) λmaxε) 220 (−3.04), 245 (−1.76), 270 (+2.32) nm; 1D NMR data, see Table 1; HRESIMS m/z 375.1550 [M + H]+ (calcd for C19H23N2O6, 375.1551).
Sorbicillasin B (2): pale yellow oil, [ α ] D 25 +10.4 (c 0.15, MeOH); UV (MeOH) λmax (log ε): 220 (2.65), 261 (2.01), 307 (1.80) nm; IR (KBr) νmax 3329, 2926, 1683, 1558, 1384, 1208, 1143, 838 cm−1, see Figure S18; ECD (1 mM MeOH) λmaxε) 225 (+1.88), 250 (+4.32), 275 (−1.90) nm; 1D NMR data, see Table 1; HRESIMS m/z 397.1376 [M + Na]+ (calcd for C19H22N2O6Na, 397.1370).
Scirpyrone K (3): white amorphous powder; UV (MeOH) λmax (log ε): 231 (1.36), 285 (2.35) nm; IR (KBr) νmax 3104, 2954, 2705, 1743, 1407, 1170, 1001, 836 cm−1, see Figure S26; 1D NMR data, see Table 2; HRESIMS m/z 213.0764 [M + H]+ (calcd for C10H13O5, 213.0757).

3.5. Biological Assay

Cytotoxic activities of 13 were evaluated using an MGC-803 cell line by the SRB (Sulforhodamine B) method [14] and the K562 cell line by the MTT method [15]. The positive control was doxorubicin hydrochloride. In the DPPH scavenging assay [16], samples to be tested were dissolved in MeOH and the solution (160 μL) was dispensed into wells of a 96-well microtiter tray. Forty microliters of the DPPH solution in MeOH were added to each well. The mixture was shaken and left to stand for 30 min. After the reaction, absorbance was measured at 510 nm, and the percent inhibition was calculated. IC50 values denoted the concentration of sample required to scavenge 50% of the DPPH free radicals [27].

3.6. Computation Section

Conformational searches were run by employing the “systematic” procedure implemented in Spartan′14 [28] using MMFF (Merck molecular force field), which were all reoptimized with DFT calculations at the B3LYP/6-31+G(d) level using the Gaussian09 program [29]. The geometry of various initial conformations was optimized. Vibrational frequency calculations confirmed the presence of minima. Time-dependent DFT calculations were performed on the three lowest-energy conformations for (7R,11S)-1a and three lowest-energy conformations for (7S,11S)-1b (>4% population) using 30 excited states and a polarizable continuum model (PCM) for MeOH. ECD spectra were generated using the program SpecDis [30] by applying a Gaussian band shape with 0.30 eV width for 1a and 0.35 eV width for 1b, from dipole length rotational strengths. The dipole velocity forms yielded negligible differences. The spectra of the conformers were combined using Boltzmann weighting, with the lowest-energy conformations accounting for 100% of the weights. The calculated spectra were shifted for 1a (4 nm) and for 1b (0 nm) to facilitate comparison to the experimental data.

4. Conclusions

In summary, two new nitrogen-containing sorbicillinoids, one new 3,4,6-trisubstituted α-pyrone derivative, and two known biosynthetically related polyketides were isolated from the deep-sea-derived fungus Phialocephala sp. FL30r. The absolute configurations of new compounds 12 were determined by NMR and TD-DFT calculations of specific ECD spectra. Compounds 1 and 2 were unusual naturally occurring nitrogen-containing sorbicillinoid derivatives with a novel hexahydropyrimido[2,1-a] isoindole moiety. Pyrone 3 exhibited radical scavenging activity against DPPH.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/16/7/245/s1: the HPLC analysis of the metabolic extracts, MS, IR, 1D, and 2D NMR spectra for compounds 13, and details for ECD calculations. Figure S1: HPLC analysis of the metabolic extracts from different conditions; Figures S2–S10: 1D, 2D NMR, NOESY, HRESIMS, and IR spectra of sorbicillasin A (1); Figures S11–S18: 1D, 2D NMR, NOESY, HRESIMS, and IR spectra of sorbicillasin B (2); Figures S19–S26: 1D, 2D NMR, HRESIMS, and IR spectra of scirpyrone K (3); Figure S27: ECD calculation of 1a; Figure S28: ECD calculation of 1b.

Author Contributions

The contributions of the respective authors are listed as follows: Z.Z. drafted the work. Z.Z. and X.H. performed the fermentation, extraction, isolation, and structural elucidation of the constituents. Q.C., G.Z., T.Z. and Q.G. contributed to checking and confirming all of the procedures of the isolation and the structural elucidation. D.L. designed the study, supervised the laboratory work, and contributed to the structural determination, bioactivity evaluation and critical reading and revision of the manuscript. All the authors have read the final manuscript and approved the submission.

Funding

This work was financially supported by the NSFC-Shandong Joint Fund for Marine Science Research Centers (U1606403), the Qingdao National Laboratory for Marine Science and Technology (2015ASKJ02 and 2016ASKJ08-02), Shandong province key research and development program (2016GSF201204) and Fundamental Research Funds for the Central Universities (201562016), Qingdao National Laboratory for Marine Science and Technology (No. 2016ASKJ08-02).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hoffmeister, D.; Keller, N.P. Natural products of filamentous fungi: Enzymes, genes, and their regulation. Nat. Prod. Rep. 2007, 24, 393–416. [Google Scholar] [CrossRef] [PubMed]
  2. Sanchez, J.F.; Somoza, A.D.; Keller, N.P.; Wang, C.C.C. Advances in Aspergillus secondary metabolite research in the post-genomic era. Nat. Prod. Rep. 2012, 29, 351–371. [Google Scholar] [CrossRef] [PubMed]
  3. Wang, H.; Eze, P.M.; Hoefert, S.P.; Janiak, C.; Hartmann, R.; Okoye, F.B.C.; Esimone, C.O.; Orfali, R.S.; Dai, H.; Liu, Z.; et al. Substituted l-tryptophan-l-phenyllactic acid conjugates produced by an endophytic fungus Aspergillus aculeatus using an OSMAC approach. RSC Adv. 2018, 8, 7863–7872. [Google Scholar] [CrossRef]
  4. Meng, L.H.; Li, X.M.; Liu, Y.; Xu, G.M.; Wang, B.G. Antimicrobial alkaloids produced by the mangrove endophyte Penicillium brocae MA-231 using the OSMAC approach. RSC Adv. 2017, 7, 55026–55033. [Google Scholar] [CrossRef]
  5. Yuan, C.; Guo, Y.H.; Wang, H.Y.; Ma, X.J.; Jiang, T.; Zhao, J.L.; Zou, Z.M.; Ding, G. Allelopathic polyketides from an endolichenic fungus Myxotrichum sp. by using OSMAC strategy. Sci. Rep. UK 2016, 6, 19350. [Google Scholar] [CrossRef] [PubMed]
  6. Guo, W.; Zhang, Z.; Zhu, T.; Gu, Q.; Li, D. Penicyclones A-E, antibacterial polyketides from the deep sea-derived fungus Penicillium sp. F23-2. J. Nat. Prod. 2015, 78, 2699–2703. [Google Scholar] [CrossRef] [PubMed]
  7. Li, D.; Wang, F.; Xiao, X.; Fang, Y.; Zhu, T.; Gu, Q.; Zhu, W. Trisorbicillinone A, a novel sorbicillin trimer, from a deep ocean sediment derived fungus, Phialocephala sp. FL30r. Tetrahedron Lett. 2007, 48, 5235–5238. [Google Scholar] [CrossRef]
  8. Li, D.; Wang, F.; Cai, S.; Zeng, X.; Xiao, X.; Gu, Q.; Zhu, W. Two new bisorbicillinoids isolated from a deep-sea fungus, Phialocephala sp. FL30r. J. Antibiot. 2007, 60, 317–320. [Google Scholar] [CrossRef] [PubMed]
  9. Li, D.; Cai, S.; Zhu, T.; Wang, F.; Xiao, X.; Gu, Q. Three new sorbicillin trimers, trisorbicillinones B, C, and D, from a deep ocean sediment derived fungus, Phialocephala sp. FL30r. Tetrahedron 2010, 66, 5101–5106. [Google Scholar] [CrossRef]
  10. Li, D.H.; Cai, S.X.; Zhu, T.J.; Wang, F.P.; Xiao, X.; Gu, Q.Q. New cytotoxic metabolites from a deep-sea-derived fungus, Phialocephala sp., strain FL30r. Chem. Biodivers. 2011, 8, 895–901. [Google Scholar] [CrossRef] [PubMed]
  11. Washida, K.; Abe, N.; Sugiyama, Y.; Hirota, A. Novel DPPH radical scavengers, demethylbisorbibutenolide and trichopyrone, from a fungus. Biosci. Biotechnol. Biochem. 2007, 71, 1052–1057. [Google Scholar] [CrossRef] [PubMed]
  12. Yang, Y.; Yang, F.; Miao, C.; Liu, K.; Li, Q.; Qin, S.; Zhao, L.; Ding, Z. Antifungal metabolites from the rhizospheric Penicillium sp. YIM PH 30003 associated with Panax notoginseng. Phytochem. Lett. 2015, 11, 249–253. [Google Scholar] [CrossRef]
  13. Tian, J.F.; Yu, R.J.; Li, X.X.; Gao, H.; Guo, L.D.; Tang, J.S.; Yao, X.S. 1H and 13C NMR spectral assignments of 2-pyrone derivatives from an endophytic fungus of Sarcosomataceae. Magn. Reson. Chem. 2015, 53, 866–871. [Google Scholar] [CrossRef] [PubMed]
  14. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107–1112. [Google Scholar] [CrossRef] [PubMed]
  15. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
  16. Chen, Y.; Wang, M.; Rosen, R.T.; Ho, C.T. 2,2-Diphenyl-1-picrylhydrazyl radical-scavenging active components from Polygonum multiflorum Thunb. J. Agric. Food Chem. 1999, 47, 2226–2228. [Google Scholar] [CrossRef] [PubMed]
  17. Meng, J.; Wang, X.; Xu, D.; Fu, X.; Zhang, X.; Lai, D.; Zhou, L.; Zhang, G. Sorbicillinoids from fungi and their bioactivities. Molecules 2016, 21, 715. [Google Scholar] [CrossRef] [PubMed]
  18. Bringmann, G.; Lang, G.; Gulder, T.A.M.; Tsuruta, H.; Muhlbacher, J.; Maksimenka, K.; Steffens, S.; Schaumann, K.; Stohr, R.; Wiese, J.; et al. The first sorbicillinoid alkaloids, the antileukemic sorbicillactones A and B, from a sponge-derived Penicillium chrysogenum strain. Tetrahedron 2005, 61, 7252–7265. [Google Scholar] [CrossRef]
  19. Cabrera, G.M.; Butler, M.; Rodriguez, M.A.; Godeas, A.; Haddad, R.; Eberlin, M.N. A sorbicillinoid urea from an intertidal Paecilomyces marquandii. J. Nat. Prod. 2006, 69, 1806–1808. [Google Scholar] [CrossRef] [PubMed]
  20. Guo, W.; Peng, J.; Zhu, T.; Gu, Q.; Keyzers, R.A.; Li, D. Sorbicillamines A-E, nitrogen-containing sorbicillinoids from the deep-sea-derived fungus Penicillium sp. F23-2. J. Nat. Prod. 2013, 76, 2106–2112. [Google Scholar] [CrossRef] [PubMed]
  21. Trifonov, L.S.; Dreiding, A.S.; Hoesch, L.; Rast, D.M. Isolation of four hexaketides from Verticillium intertextum. Helv. Chim. Acta 1981, 64, 1843–1846. [Google Scholar] [CrossRef]
  22. Miklos, F.; Bozo, K.; Galla, Z.; Haukka, M.; Fulop, F. Traceless chirality transfer from a norbornene β-amino acid to pyrimido[2,1-a]isoindole enantiomers. Tetrahedron Asymmetr. 2017, 28, 1401–1406. [Google Scholar] [CrossRef]
  23. Houlihan, W.J.; Kelly, L.; Pankuch, J.; Koletar, J.; Brand, L.; Janowsky, A.; Kopajtic, T.A. Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter. J. Med. Chem. 2002, 45, 4097–4109. [Google Scholar] [CrossRef] [PubMed]
  24. Miklos, F.; Toth, Z.; Haenninen, M.M.; Sillanpaeae, R.; Forro, E.; Fueloep, F. Retro-Diels-Alder protocol for the synthesis of pyrrolo[1,2-a]pyrimidine and pyrimido[2,1-a] isoindole enantiomers. Eur. J. Org. Chem. 2013, 2013, 4887–4894. [Google Scholar] [CrossRef]
  25. Yu, G.; Wang, S.; Wang, L.; Che, Q.; Zhu, T.; Zhang, G.; Gu, Q.; Guo, P.; Li, D. Lipid-lowering polyketides from the fungus Penicillium Steckii HDN13-279. Mar. Drugs 2018, 16, 25. [Google Scholar] [CrossRef] [PubMed]
  26. Zhang, Z.; He, X.; Zhang, G.; Che, Q.; Zhu, T.; Gu, Q.; Li, D. Inducing secondary metabolite production by combined culture of Talaromyces aculeatus and Penicillium variabile. J. Nat. Prod. 2017, 80, 3167–3171. [Google Scholar] [CrossRef] [PubMed]
  27. Guo, W.; Kong, X.; Zhu, T.; Gu, Q.; Li, D. Penipyrols A-B and peniamidones A-D from the mangrove derived Penicillium solitum GWQ-143. Arch. Pharm. Res. 2015, 38, 1449–1454. [Google Scholar] [CrossRef] [PubMed]
  28. Spartan’ 14; Wavefunction Inc.: Irvine, CA, USA, 2013.
  29. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09; Revision A.1; Gaussian, Inc.: Wallingford, CT, USA, 2009. [Google Scholar]
  30. Bruhn, T.; Hemberger, Y.; Schaumlöffel, A.; Bringmann, G. SpecDis, Version 1.53; University of Wuerzburg: Wurzburg, Germany, 2011. [Google Scholar]
Figure 1. Structures of compounds 15.
Figure 1. Structures of compounds 15.
Marinedrugs 16 00245 g001
Figure 2. Key COSY and HMBC correlations of compounds 13.
Figure 2. Key COSY and HMBC correlations of compounds 13.
Marinedrugs 16 00245 g002
Figure 3. Key NOESY correlations of compounds 1 and 2.
Figure 3. Key NOESY correlations of compounds 1 and 2.
Marinedrugs 16 00245 g003
Figure 4. Experimental ECD spectrum of 1 (black curve) and that calculated from the truncated model 1a (red curve) (0.30 eV).
Figure 4. Experimental ECD spectrum of 1 (black curve) and that calculated from the truncated model 1a (red curve) (0.30 eV).
Marinedrugs 16 00245 g004
Figure 5. Experimental ECD spectrum of 2 (black curve) and that calculated from the truncated model 1b (blue curve) (0.35 eV).
Figure 5. Experimental ECD spectrum of 2 (black curve) and that calculated from the truncated model 1b (blue curve) (0.35 eV).
Marinedrugs 16 00245 g005
Figure 6. Possible biosynthetic pathway of compounds 1 and 2.
Figure 6. Possible biosynthetic pathway of compounds 1 and 2.
Marinedrugs 16 00245 g006
Table 1. 1H (500 MHz) and 13C (125 MHz) NMR data of compounds 1 and 2 (DMSO-d6, δ ppm).
Table 1. 1H (500 MHz) and 13C (125 MHz) NMR data of compounds 1 and 2 (DMSO-d6, δ ppm).
No.12
δCδH, Mult. (J in Hz)δCδH, Mult. (J in Hz)
1125.6 125.6
2115.6 115.8
3155.7 155.8
4118.9 119.2
5148.4 148.4
6124.8 130.7
775.2 75.2
9167.1 168.0
1031.02.48 dd (17.1, 6.0), H-10a
2.82 dd (17.1, 6.0), H-10b
34.02.35 m, H-10a
2.61 m, H-10b
1148.24.94 t (7.55)50.24.31 s
13169.0 169.5
1410.12.38 s10.22.33 s
1510.72.11 s10.72.10 s
1636.92.41 dt (11.8, 4.0)
1.90 dt (11.8, 4.0)
35.92.45 m
2.13 m
1727.11.80 dt (11.8, 5.8)
1.12 dt (11.8, 5.8)
27.31.66 m
1.32 m
18130.45.19 m130.55.24 m
19124.85.17m125.15.19 m
2018.21.48 d (4.2)18.31.48 d (5.7)
21172.6 171.4
3-OH 8.62 s 8.60 s
5-OH 8.77 s 8.76 s
8-NH 8.04 s 8.03 s
21-OH 13.12 brs 12.74 brs
Table 2. 1H (500 MHz) and 13C (125 MHz) NMR data of compound 3 (DMSO-d6, δ ppm).
Table 2. 1H (500 MHz) and 13C (125 MHz) NMR data of compound 3 (DMSO-d6, δ ppm).
No.3 a
δCδH, Mult. (J in Hz)
2165.3
397.3
4165.2
599.95.98 s
6161.2
728.42.67 t (6.95)
830.22.59 t (6.95)
9172.4
1052.03.58 s
118.81.72 s
4-OH 11.15 brs
a Recorded in DMSO.

Share and Cite

MDPI and ACS Style

Zhang, Z.; He, X.; Che, Q.; Zhang, G.; Zhu, T.; Gu, Q.; Li, D. Sorbicillasins A–B and Scirpyrone K from a Deep-Sea-Derived Fungus, Phialocephala sp. FL30r. Mar. Drugs 2018, 16, 245. https://doi.org/10.3390/md16070245

AMA Style

Zhang Z, He X, Che Q, Zhang G, Zhu T, Gu Q, Li D. Sorbicillasins A–B and Scirpyrone K from a Deep-Sea-Derived Fungus, Phialocephala sp. FL30r. Marine Drugs. 2018; 16(7):245. https://doi.org/10.3390/md16070245

Chicago/Turabian Style

Zhang, Zhenzhen, Xueqian He, Qian Che, Guojian Zhang, Tianjiao Zhu, Qianqun Gu, and Dehai Li. 2018. "Sorbicillasins A–B and Scirpyrone K from a Deep-Sea-Derived Fungus, Phialocephala sp. FL30r" Marine Drugs 16, no. 7: 245. https://doi.org/10.3390/md16070245

APA Style

Zhang, Z., He, X., Che, Q., Zhang, G., Zhu, T., Gu, Q., & Li, D. (2018). Sorbicillasins A–B and Scirpyrone K from a Deep-Sea-Derived Fungus, Phialocephala sp. FL30r. Marine Drugs, 16(7), 245. https://doi.org/10.3390/md16070245

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop